1-14 of 14
Centanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Children and Adolescents with ADHD
Innovations In MedicineCentanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Children and Adolescents with ADHD
Jennifer Caudle, DO, FACOFP
Greg Mattingly, MD
The Positive Impact of Electroconvulsive Therapy for Severe Psychiatric Illness
Medical Industry FeatureThe Positive Impact of Electroconvulsive Therapy for Severe Psychiatric Illness
Leonardo Lopez, M.D.
Jared Stroud, MD
Clay Jackson, MD
Anton P. Porsteinsson, MD
Seeing the Full Picture of ADHD: Beyond Core Symptoms
Innovations In MedicineSeeing the Full Picture of ADHD: Beyond Core Symptoms
Andrew J. Cutler, MD
Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC
Debunking Five Misconceptions in Agitation in Alzheimer’s Dementia
Medical Industry FeatureDebunking Five Misconceptions in Agitation in Alzheimer’s Dementia
Clay Jackson, MD
Amita Patel, MD, CMD
Depression from Case to Clinic: Rethinking Partial Response with a Different Approach
Medical Industry FeatureDepression from Case to Clinic: Rethinking Partial Response with a Different Approach
Ashley Baker, MSN, PMHNP
Kimberly Giberga, MSN, APRN, FNP-C, PMHNP-BC
Bradford Perkins, MD
- advertisement
Is It Time to Rethink How We Support Depression Management?
Medical Industry FeatureIs It Time to Rethink How We Support Depression Management?
Charles Turck, PharmD, BCPS, BCCCP
Andrew J. Cutler, MD
Gustavo Alva, MD, DFAPA
Engaging Neuroplasticity in Depression with Cognitive-Emotional Training
Medical Industry FeatureEngaging Neuroplasticity in Depression with Cognitive-Emotional Training
Charles Turck, PharmD, BCPS, BCCCP
Brian Iacoviello, PhD
From Monoamines to Neurocircuits: Our Evolving Understanding of Depression
Medical Industry FeatureFrom Monoamines to Neurocircuits: Our Evolving Understanding of Depression
Charles Turck, PharmD, BCPS, BCCCP
Joseph Goldberg, MD
Neuroplasticity: A Potential Target for the Treatment of Depression
Medical Industry FeatureNeuroplasticity: A Potential Target for the Treatment of Depression
Charles Turck, PharmD, BCPS, BCCCP
Madhukar H. Trivedi, MD
Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
Medical Industry FeatureAgitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
Charles Turck, PharmD, BCPS, BCCCP
George Grossberg, MD
Angela Sanford, MD, CMD
Research Uncovers a Potential Biomarker for Postpartum Depression Risk
Medical Industry FeatureResearch Uncovers a Potential Biomarker for Postpartum Depression Risk
Lauren Osborne, M.D.
- advertisement
A Treatment for Schizophrenia in Adults
Psychiatry and Mental HealthA Treatment for Schizophrenia in Adults
Matt Birnholz, MD
Roger McIntyre, MD
A Treatment for Acute Manic or Mixed Episodes of Bipolar I Disorder in Adults
Psychiatry and Mental HealthA Treatment for Acute Manic or Mixed Episodes of Bipolar I Disorder in Adults
Matt Birnholz, MD
Roger McIntyre, MD
